[1]
ASHISH JAIN, ABHISHEK SENGUPTA, and PRIYANKA NARAD, “CONSTITUTIVELY ACTIVATED TYROSINE KINASE INHIBITOR DRUG DESIGN: HOMOLOGY MODELING AND DOCKING STUDIES ON CHRONIC MYELOGENOUS LEUKEMIA BCR-ABL FUSION PROTEIN”, ijpbs, vol. 6, no. 2, pp. 1215–1225, Jun. 2015.